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Cell surface expressionof typeAGABAreceptors (GABAARs)
is a critical determinant of the efficacy of inhibitory neurotrans-
mission. Pentameric GABAARs are assembled from a large pool
of subunits according to precise co-assembly rules that limit the
extent of receptor structural diversity. These rules ensure that
particular subunits, such as 1 and 3, form functional cell sur-
face ion channels when expressed alone in heterologous sys-
tems, whereas other brain-abundant subunits, such as  and ,
are retained within intracellular compartments. Why some of
the most abundant GABAAR subunits fail to form homomeric
ion channels is unknown. Normally, surface expression of and
 subunits requires co-assemblywith subunits via interactions
between their N-terminal sequences in the endoplasmic reticu-
lum. Here, using molecular biology, imaging, and electrophysi-
ology with GABAAR chimeras, we have identified two critical
residues in the transmembrane domains of  and  subunits,
which, when substituted for their 1 counterparts, permit cell
surface expression as homomers. Consistent with this, substitu-
tion of the 1 transmembrane residues for the  subunit equiv-
alents reduced surface expression and altered channel gating,
highlighting their importance for GABAAR trafficking and sig-
naling. Although not ligand-gated, the formation of  and 
homomeric ion channels at the cell surface was revealed by
incorporating a mutation that imparts the functional signature
of spontaneous channel activity. Our study identifies two single
transmembrane residues that enable homomeric GABAAR sub-
unit cell surface trafficking and demonstrates that  and  sub-
units can form functional ion channels.
GABA plays a central role in neurotransmission by exerting
inhibitory control over neuronal excitation. Dysfunctional
GABAergic neurotransmission is associated with many neuro-
logical conditions, including epilepsy (1), anxiety (2), and neu-
rodevelopmental disorders (3). The cellular effects ofGABAare
orchestrated by ionotropic type A GABA receptors (GABAARs)3
and by metabotropic GABAB receptors. The activation of
inhibitory Cl and K conductances via these two receptor
classes hyperpolarize and electrically shunt neurons to control
excitation (4). GABAARs are expressed within and outside of
inhibitory synapses, and their cell surface expression levels crit-
ically determine inhibitory efficacy.
GABAARs are pentamers constructed from combinations of
19 subunits (1–6,1–3,1–3, , 1–3, ,, and 	) (5, 6). Their
abundance depends on the brain region and cellular location.
The prototypical GABAAR is a heteropentamer comprising 2
and 2 with either  or  subunits (7). In heterologous expres-
sion systems (HEK293 cells orXenopus oocytes), and the long
isoform of  subunits (2L) do not travel to the cell surface
alone, as determined by biochemical, imaging, and electro-
physiological methods (8–10). Formation of functional cell
surface ion channels requires co-assembly with  subunits in
the endoplasmic reticulum (8, 9). Assembly of the pentamer is
proposed to stabilize receptor conformation, permitting its
trafficking to the cell surface (11). To date, only 1 and 3 sub-
units have been reported to be robustly expressed at the
cell surface of heterologous expression systems as functional
homomers (12–16). In addition,  subunits can also traffic to
the cell surface but do not form functional ion channels (17).
The trafficking itineraries of 1 and 3 functional homomers
indicate that, normally,  and  subunits are internally seques-
tered in the absence of  subunits, suggesting the presence of
intracellular retention signals.
Several sequence motifs have been described for , , and 
subunits that facilitate heteropentameric assembly (18–21).
These motifs are located in the N-terminal extracellular
domains (ECDs), and their deletion or substitution abolishes
oligomerization in biochemical assays (18–20, 22–24). The
location of thesemotifs implies that interfacial subunit interac-
tions are important for receptor trafficking to the cell surface.
However, what prevents surface expression of the most abun-
dant GABAAR  and  subunits in the absence of heteromeric
subunit co-assembly remains unknown.
We addressed this issue by identifying residues that affected
homomeric GABAAR surface trafficking using imaging with a
fluorophore-linked -bungarotoxin (BgTx) bound to a mimo-
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tope representing the BgTx-binding site (BBS) (25–27) inserted
into the subunit’s ECD. The role of the transmembrane domain
(TMD) was examined in assembly using chimeras, and the
intracellular domains (ICDs) between M1–M2 and M3–M4
were assessed using domain swaps with the prokaryotic recep-
tor homologue from Gloeobacter violaceus, GLIC. Our results
provide a new framework for understanding homomeric
GABAAR trafficking based on single TMD residues that enable
functional cell surface assembly of  and  subunit homomers.
Results
Switching domains in1 subunits
To understand why the cell surface expression profiles for 
and  subunits differ, we created chimeras incorporating
domain switches. We used the prototypic 1 subunit incorpo-
rating a BBS (1BBS; Fig. 1A) to allow specific labeling with
Alexa 555–conjugatedBgTx (Fig. S1,A andB). As expected (20,
28), 1BBS did not express on the surface of HEK293 cells, evi-
dent by an absence of BgTx-AF555 labeling at the cell periph-
ery; however, intracellular fluorescence was observed in per-
meabilized cells (Fig. S1,A andB). By contrast, co-expression of
1 with  and  subunits permitted robust surface expression
(p  0.001; Fig. 1, B and C). The inserted BBS motif did not
unduly affect receptor function because activation by GABA of
 receptors in HEK293 cells revealed only a small (2.6-fold)
decrease in GABA sensitivity compared with WT receptors
(EC50122L 8.3 1.4
M, n 6;1BBS22L 20.4 3.1
M,
n 12; Fig. S1C).
The importance of the1BBS ICDs (betweenM1–M2 (ICD1)
and M3–M4 (ICD2)) for surface expression was investigated
next by substitution with the ICD sequence from GLIC,
-SQPARAA-. GLIC is a part of the pentameric ligand-gated ion
channel family (29). The GLIC heptapeptide ICD is frequently
used in structural studies to stabilize GABAARs for X-ray crys-
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Figure1. Transmembranedomains1and3control thesurfaceexpressionofhomomericGABAAR1subunits.A, schematicof themouseGABAAR1subunit,
showing the BBS (green) and bound-BgTx coupled to AF555 (red). B, confocal images for cell surface1BBS expressed alone orwith2 and 2L subunits in HEK293
cells.C, analysisofcell surfaceexpression for1BBSand1BBS22L inHEK293cells.Note that1subunits reachthesurfaceonlywith2and2subunits.D, schematic
of receptor constructs and confocal images for 1 subunits with ICD1, ICD2, or ICD1–2 replaced by the GLIC M3–M4 sequence -SQPARAA- (purple). E, cell surface
expressionof1BBS22L (fromB) and1 subunit ICD1, ICD2, and ICD1–2 substitutedwithGLICM3–M4. F, schematic of receptor constructs and confocal images for
1 subunitswith ICD1, ICD2,or ICD1–2 replacedbyamultipleGly-Ser flexible linker, -GGSSGGSS- (purple).G, cell surfaceexpressionof1BBS22Land the1 subunit
with ICD1, ICD2, and ICD1–2 substituted by a Gly-Ser linker.H, confocal images for 1BBS–1 chimeras, including 1BBS–1M1/M3, 1BBS–1M1, and 1BBS–1M3. I, cell
surface fluorescence for1BBS–1chimeras. These and similar data inother figures arenormalized to cell surface labeling forWT1BBS22L receptors.Data in all bar
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tallization (30–31) and is therefore also useful to explore the
properties of the  subunit ICDs. In addition, we studied the
role of ICDs in assembly using an alternative set of constructs
where the ICDswere replacedwithGly-Ser flexible linkers. The
critical nature of this region is further demonstrated by the
substitution of intracellular residues at the base of the trans-
membrane  helices, which can affect signaling via GABAARs
(32).
Both GLIC ICD- and Gly-Ser–containing 1 subunits were
absent from the cell surface, with low fluorescence intensities
similar to background, and significantly lower compared with
1BBS22L receptors (p  0.001; Fig. 1, D–G) even though
intracellular labeling of permeabilized cells was observed (Fig.
S2, A and B) and the GLIC and Gly-Ser ICD–containing chi-
meras expressed on the cell surface with 22L subunits (Fig.
S2, C and D). We initially considered that the ICD may be
important for trafficking because 2L subunits are retained in
the ER, contrasting with the alternatively spliced 2S isoform
that differs only by the deletion of an eight-amino acid motif in
the ICD (10).
Nevertheless, substitution of the ICDs separately or together,
with either GLIC or Gly-Ser linkers, did not permit  subunit
access to the cell surface.We also consideredwhether theGLIC
heptapeptide induced a dominant negative effect on expres-
sion, but this is unlikely given the successful expression of 3
homomers incorporating the GLIC ICD (30) and the clear cell
surface expression of  and 2L subunits, also incorporating
GLIC ICDs, as  heteromers. We therefore eliminated the
ICDs from further investigation as a reason for intracellular
retention of  and 2L subunits. We took this decision even
though we know from previous work that 2S can traffic to the
cell surface but then fails to form oligomers or functional ion
channels, and it is significantly internalized (10).
Given that 1 subunits form cell surface homomers, the role
of the TMD in subunit trafficking was assessed by forming
domain swap chimeras between the 1BBS and 1 subunits.
These include1BBS-1M1–4;1BBS and 1M1 andM2 (1BBS-
1M1/2), 1BBS and 1 ICD2  M4 (1BBS-1ICD2-M4), and
1BBS ECD and 1M4 (1BBS-1M4). However, all of these con-
structs failed to traffic to the cell surface, as determined by
using BgTx–Alexa 555 (Fig. S3, A and B, p 0.001). Neverthe-
less, intracellular labeling was evident in permeabilized cells,
suggesting that these chimeras were retained in intracellular
compartments (Fig. S3,C andD, p 0.001). By contrast, 1-1
chimeras composed of 1BBS with 1 M3, ICD2, and M4
(1BBS-1M3-M4) and 1BBS with 1 M1 and M3 (1BBS-
1M1/M3) both showed clear surface expression (Fig. S3,A andB
and Fig. 1, H and I; p  0.001). Given that 1BBS-1M4 and
1BBS-1M1/M2 were not assembled at the cell surface, we next
examined a chimera formed from1BBS and just 1M3 (1BBS-
1M3). This also showed robust surface expression (Fig. 1, H
and I; p 0.001) suggesting an important role for M3 residues
in surface trafficking of 1 subunits.
In addition, because 1BBS-1M1/M3 was expressed at the cell
surface, we examined the contribution of M1 to surface traf-
ficking. A new chimera comprising 1BBS ECD and 1 M1
(1BBS-1M1) also revealed strong cell surface labeling (Fig. 1,H
and I; p 0.05). Together, these results reveal the existence of
two discrete areas in M1 and M3 of the 1 TMD that control
cell surface expression.
Two TMD residues independently control cell surface
expression of1 subunits
To identify the critical amino acids involved in cell surface
expression of the 1BBS-1M1/M3 chimeras, we compared the
primary sequences for M1 and M3 between 1–6 and 1 sub-
units. Although the M1 sequences were highly conserved,
nonhomologous exchanges were identified (Fig. 2A). Using the
mouse 1 subunit as a template, we sequentially substituted
three highly conserved M1 residues with nonhomologous
equivalents from 1M1. Two of these substitutions, C233A and
M235L, did not enable1 subunits to reach the cell surface (Fig.
S4, A and B), even though intracellular labeling was observed
(Fig. S4, C and D). However, Q241W, which is located at the
base of M1, caused robust cell surface expression (Fig. 2, C–E;
Fig. S4, A and B; p 0.001), indicating a key role in the surface
trafficking of 1 subunits.
Comparing sequences for M3 across 1–6 and 1 subunits
revealed similar high levels of residue conservation (Fig. 2B).
Substituting several nonhomologous residues in 1M3 for their
1M3 equivalents, including C292S and the triple switch S298L,
A299S, and L300V (1SAL-LSV), revealed no effect on cell sur-
face expression, only intracellular retention (Fig. 2, C and D,
and Fig. S4; p  0.001). However, the substitution 1A290W,
which is located at the top of M3, enabled robust surface
expression comparable with that for1-containing heteromers
(Fig. 2,C andD, and Fig. S4,A and B; p 0.001). Thus, position
290 inM3 is another critical determinant for surface expression
of 1 subunits.
To unequivocally demonstrate that these point mutations
permit cell surface expression of 1 subunits, we used double
labeling with different fluorophores coupled to BgTx. HEK293
cells expressing BBS-tagged WT 1 (1WT), 1Q241W, or
1A290W were incubated in Alexa Fluor 488–BgTx. Then, after
fixation and permeabilization, we incubated with Alexa Fluor
555–BgTx and an antibody for the endoplasmic reticulum (ER)
marker calnexin. This revealed that, although 1Q241W and
1A290W reach the cell surface, WT 1 subunits are retained in
the ER (Fig. 2, C and D; p 0.001).
To determine the nature of the residues enabling cell surface
expression of 1 subunits, Gln-241 was exchanged for alterna-
tives with small (Gly), hydrophobic (Ala, Met), positively
charged (Lys), negatively charged (Asp), polar (Asn, Ser), or
aromatic (Phe, Tyr) side chains. None of these substitutions
permitted cell surface expression compared with Q241W (p
0.001), although intracellular labeling was evident for all
mutants (Fig. 2E and Fig. S5; p 0.05). Similar examination of
Ala-290 by substitutionwithAsp,Met, Gln, orAsn also failed to
promote cell surface expression of 1 subunits (p  0.001),
although again, intracellular labeling was evident, suggesting
that these subunits fold correctly in the ER (Fig. 2E and Fig. S6;
p  0.05). Interestingly, substitution of Ala-290 by Phe or Tyr
resulted in cell surface expression, albeit at a lower level com-
pared with A290W (Fig. S6, A and B). Together, these results
indicate that substitution of the highly conservedM1 residue to
tryptophan (from 1) or the M3 residue to aromatic amino
GABAA receptor trafficking
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acids (tryptophan in 1), allows cell surface expression of 1
subunits.
1 subunits form functional homomeric ion channels
To determine whether cell surface 1Q241W and 1A290W
formed functional ion channels, a leucine residue inM2 (9’) was
exchanged for serine (L9’S). This was necessary to confer spon-
taneous channel activation (33) because  homomers lack a
GABA binding site because of the absence of  subunits. Cells
expressing either 1Q241W,L9’S or 1A290W,L9’S exhibited spon-
taneous activity, as revealed by the GABAAR channel blocker
picrotoxin, which caused inhibition in a concentration-depen-
dent manner (Fig. 3, A and B).
When expressed in HEK293 cells, 1Q241W or 1A290W
homomers were not activated by GABA (1 mM), pentobarbi-
tone (50 
M), the neurosteroid tetrahydrodeoxycorticosterone
(THDOC, 10 
M), or zolpidem (100 
M), which has been
reported to bind to – interfaces (34). However, the sponta-
neous current induced by L9Swas inhibited by pentobarbitone
(50 
M), pregnenolone sulfate (10 
M), and bicuculline (200

M) but not by GABA, THDOC, or zolpidem (Fig. 3C). When
homomeric 1 receptors lacking L9’S were expressed in Xeno-
pus oocytes, no activation of 1Q241W and 1A290W was
observed with GABA (100mM), pentobarbitone (1 mM), or zol-
pidem (100 
M) (data not shown). However, by including L9’S,
GABA evoked small currents for 1Q241W,L9’S and 1A290W,L9’S
homomers, and pentobarbitone, pregnenolone sulfate, bicucul-
line, and zolpidem all blocked the spontaneous currents (Fig.
3D). Interestingly, THDOC (10
M) caused a large activation of
1A290W,L9’S but not 1Q241W,L9’S, followed by slow deactiva-
tion (35). Glutamine 241 forms a key part of the neurosteroid
binding site (35), and its substitution with tryptophan
(1Q241W) can mimic a neurosteroid-bound state. This may
enable the release of 1 subunits from intracellular compart-
ments to the cell surface. However, treating HEK293 cells
expressing just 1 subunits with THDOC (up to 10
M) did not
enable 1 subunit trafficking to the cell surface (Fig. S7). These
results indicate that 1 subunits incorporating single muta-
tions in the TMD can assemble into functional homomeric ion
channels on the cell membrane.
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A conserved amino acid controls the cell surface expression
of2
The 2L subunit, similar to 1, is also unable to access the
plasma membrane as a functional homomer (9, 10, 36). Com-
paring the primary sequences inM1andM3across2L,1, and
1 subunits revealed a tryptophan (Trp-252) in 2M1 (present
also in 1M1) in the same position as Gln-241 in 1M1 (Fig. 4A).
In addition, in 2M3, a serine (Ser-301) occupies the equivalent
1A290 site (Fig. 4B). Mutating Ser-301 to tryptophan
(2LS301W) allowed 2L subunits to access the cell surface, as
evident from surface fluorescence after immunolabeling with a
2 antibody. Similar surface labeling was evident for WT het-
eromeric receptors but not forWT 2L alone (Fig. 4,C and
D; p  0.001). In addition, mutating the 2M1 Trp-252 to glu-
tamine in the 2LS301W background (2LW252Q,S301W) largely
reduced but did not abolish surface expression of 2L (Fig. 4, C
and D; p 0.01).
These results suggest that exchanging S301W in 2LM3
enables access to the cell surface and thatmutating another2L
tryptophan in M1 (to Gln, the 1Gln-241-equivalent site) partly
prevented this. This implies the existence of multiple traffick-
ing determinants in addition to the ER retention motif present
in the ICD of 2L (10).
To determine whether 2L subunits (like 1) can form func-
tional ion channels, we used the L9’S switch in 2LS301W and
expressed these receptors (2LS301W,L9’S) in HEK293 cells.
Spontaneous channel activity was evident and blocked by
picrotoxin (Fig. 4, E and F), confirming that 2L homomers
formed functional channels. In addition, 2LS301W homomers
were not activated by GABA or pentobarbitone, but spontane-
ous activity was inhibited by pentobarbitone, pregnenolone
sulfate, and bicuculline but not by GABA (Fig. 4G). By compar-
ison, expression of 2LS301W,L9’S in oocytes produced sponta-
neous currents inhibited by picrotoxin and pregnenolone
sulfate. In addition, GABA, THDOC, pentobarbitone, and
bicuculline caused minimal activation of 2LS301W,L9’S (Fig.
4H). These results highlight the importance of single M3 resi-
dues for controlling the cell surface expression of 2L subunits.
Conserved TMD residues affect the cell surface expression and
signaling of 1 homomers
Site-directed mutation of 1 and 2L indicated the impor-
tance of two tryptophans in surface trafficking and formation of
functional homomers. To investigate whether these TMD res-
idues are important for surface expression of naturally occur-
ringGABAAR homomers, we switched the 1M1 andM3 tryp-
tophans to their subunit equivalents in 1W280Q and 1W329A.
Both mutations reduced but did not abolish 1 surface expres-
sion (Fig. 5, A and B; p  0.001), suggesting that they play a
lesser role in trafficking for 1 subunits.
We also examined the role of these TMD residues in GABA
activation of 1 homomers. Differential effects were evident,
with 1W280Q increasing GABA potency by	2.5-fold (EC50
0.92 0.17 
M, n 5, p 0.05; Fig. 5, C–E), whereas 1W329A
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Figure 3. GABAAR  subunits form functional cell surface ion channels. A and B, spontaneous membrane currents revealed by picrotoxin (PTX) (A) and
concentration inhibition curves for PTX in HEK293 cells expressing 1Q241W, L9’S (IC50, 40  8 
M; n  8) and 1
A290W, L9’S (IC50, 31  5 
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M),
pregnenolone sulfate (PS, 10 
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M), THDOC (10 
M), or zolpidem (100 
M). D, membrane currents for 1L9’S receptors recorded in
Xenopus oocytes in response to GABA (100 mM), PTX (1 mM), THDOC (10 
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caused a 10-fold reduction (25.76 3.39
M,n 10, p 0.001),
as observed previously (37), compared with WT 1 receptors
(2.19 0.65 
M, n 7).
In addition, these 1mutants exhibited changed desensitiza-
tion and deactivation kinetics. Strikingly, mutating the M3
tryptophan (1W329A) markedly reduced the extent of desensi-
tization by 1 mM GABA (n 5; Fig. 5, F andG) compared with
WT 1 (n  10, p  0.001) and 1W280Q (n  13, p  0.001).
The 1W329A substitution also caused a profound increase in
the speed of current deactivation ( 0.86 0.1 s, n 7, p
0.05; Fig. 5, F and H) compared with WT 1 ( 26.9 5.6 s,
n  8) and 1W280Q, where deactivation was even slower ( 
84.4 15.1 s, n 5, p 0.001). These results indicate that the
residues controlling homomeric receptor expression in  and
L subunits also have important trafficking and gating roles for
1 homomers depending on the substituted residue.
Conserved TMD residues affect signaling of heteromers
Following the impact of the tryptophan substitutions on 1
receptor kinetics and GABA sensitivity, we next assessed their
importance for GABAAR heteromers. GABA concentration
response curves for  receptors in HEK293 cells revealed
increased GABA potency for 1Q241W22L (EC50 5.4 0.8

M, n  12), 1A290W22L (1.2  0.4 
M, n  9), and
122LS301W (6.2  1.8 
M, n  7) (for all, p  0.001) com-
pared with WT 122L (20.4 3.1 
M, n 12; Fig. 6, A–C).
The reduced EC50 values were not a consequence of  het-
eromers reflecting nonassembly of  subunits (Fig. S8) because
the mutant receptors lacked sensitivity to the  subtype–
selective blocker Zn2 at 10
M (38, 39). Thus, the tryptophans
are important for signaling via heteromeric GABAARs,
although desensitization and deactivation appeared to be
unchanged (Fig. 6D).
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Figure 4. GABAAR 2 subunits form functional cell surface ion channels. A, primary sequence alignments for 2 with 1 and 1 subunits identifying a
tryptophan (boxed,boldunderlined) inM1also found in1M1.B, a similar alignment identifies a serine in2M3 that corresponds toTrp in1M3.C, confocal images
for 2LS301W reveal cell surface expression compared with 2LWT, 2LW252Q,S301W, and the eGFP control in HEK293 cells. D, cell surface fluorescence for 2WT,
2S301W and 2LW252Q,S301W, 122L, and eGFP. E, inhibition of spontaneous currents by PTX in HEK293 cells expressing 2LS301W, L9’S. F, PTX concentration
inhibition curves for2LS301W, L9’S (IC50, 96 32
M; n 6).G, membrane currents evoked inHEK293 cells expressing2L homomeric channelswith orwithout
the L9’S substitution in response to GABA (1 mM), pentobarbitone (50 
M), pregnenolone sulfate (10 
M), or bicuculline (200 
M). H, membrane currents for
2LS301W, L9’S in Xenopus oocytes after GABA (100 mM), PTX (1 mM), THDOC (10 
M), PB (1 mM), PS (10 
M), Bic (200 
M), or zolpidem (100 
M). **, p 0.01, ***,
p 0.001, n 5–15, one-way ANOVA. Scale bar 5 
m.
GABAA receptor trafficking
13432 J. Biol. Chem. (2018) 293(35) 13427–13439
 at U
CL Library Services on O
ctober 1, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
To determine the location of these critical TMD residues in
GABAARs, we created a homology model based on the GABA
3 subunit crystal structure (30). Interestingly, the model
reveals that the key TMD residues involved in 1 and 2 sub-
unit cell surface expression are located at interface sites
between– and– subunits (for subunits) and at – (for
 subunits) (Fig. 6E).
To ascertain whether GABA activation can be imparted onto
WT 1 homomers, we substituted residues at the principal ()
interface of 1 for those that are known to be important for
GABA binding at the 2 subunit () interface (,int) (Fig.
7A) based on our structural model (Fig. 7, B–D). Four substitu-
tions (S205T, E208S, V211R, and T213S  ,int) in the 1
A290W background, 1A290W, (,int), were selected. These
new homomers were now activated by GABA but with reduced
maximum currents and GABA potency compared with
122L heteromers (Fig. 7, E and F), as might be expected by
recreating the - interface in a single  subunit.
Discussion
The efficient delivery of neurotransmitter receptors to the
cell membrane either within synaptic specialisms or to extra-
synaptic locations is important for ensuring communication
throughout the nervous system. Why some subunits are
retained within the ER whereas others, either alone (homom-
ers) or as heteromers, can access the cell surface is an important
question. This control of expression ultimately determines
the physiological and pharmacological profiles of neu-
rotransmitter receptors. For GABAARs, we know that the
ICD and ECD contain several motifs that are important for
assembly and surface expression (10, 18–20). These com-
prise several residues located in the N terminus and are most
likely expressed in the lumen of endocytic compartments
and vesicles that are unlikely to be exposed to cytosolic
adapter and trafficking proteins.
By comparison, our study identifies just two residues in the
TMD that control the trafficking of  and 2L subunits. Given
their interfacial locations, these are likely to engage in assembly
boxes between subunits. The identification of these residues
allowed the pharmacological properties of  and 2L homom-
ers to be interrogated. A single residue exchange enabled the
formation of functional  and 2L channels without the need
for auxiliary subunit co-assembly. This contrasts with WT 1
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Figure 5. Mutating M1 andM3 residues impairs trafficking and signaling of 1 homomers. A, confocal images of cell surface expression for immunola-
beled WT and mutant 1 receptors expressed in HEK293 cells. B, cell surface fluorescence for WT and mutant 1 receptors and eGFP controls. Data are
normalized to labeling for WT 1 receptors. C, representative GABA-activated current profiles for WT and mutant 1 receptors expressed in HEK293 cells. D,
concentration response profiles for WT and mutant 1 receptors. E, GABA EC50 values for activating WT and mutant 1 receptors. F, averaged activation,
desensitization, and apparent deactivation waveforms for WT and mutant 1 receptors in response to 1 mM GABA (n  5–8 currents). Waveforms were
normalized to the peak current. G, extent of peak current desensitization at the end of GABA application (percent peak). H, weighted apparent deactivation
time constants for WT and mutant 1 receptors. Deactivation data were normalized to the point at which GABA application ceased and fitted with an
exponential function. *, p 0.05; ***, p 0.001; n 5–10; one-way ANOVA. Scale bars 5 
m.
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or 2L homomers that are not expressed at the cell surface (9,
10, 36). The remarkable finding is that just single TMD residue
substitutions are sufficient to bypass stringent assembly rules,
preventing access to the cell surface. The importance of
aromatic residues for the Ala-290 site is highlighted, as substi-
tution of alanine with phenylalanine, tyrosine, and trypto-
phan all resulted in cell surface expression of 1 homomers.
The size of the aromatic side chain is likely to be important,
as the largest aromatic residue enabled the highest levels of
subunit expression.
Our study provides a mechanism for cell surface expression
of homomeric  subunits that seemingly overrides the reported
ICD ER retention sequences (10). Under physiological condi-
tions, it is plausible that the N-terminal and ICD sequences,
identified previously, operate in synchronywith the transmem-
brane residues identified here to ensure the assembly and tar-
geting of heteromeric GABAARs.
Initially, we could not activate themutant homomeric recep-
tors with GABAAR ligands but could induce spontaneous acti-
vation using the 9’ leucine switch for serine in the ion channel.
In doing so, our results provide clear evidence that  and 
subunits expressed alone are capable of forming functional
homomers on cell surface membranes following minimal
molecular change. One reason why these homomers may
have so far eluded detection is the lower resolution of bio-
chemical techniques compared with electrophysiology for
resolving low-affinity interactions of subunits in homomeric
channel complexes.
The TMD residues that affect homomeric receptor assembly
when exchanged in 1 subunits also revealed a significant
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Figure 6. Mutating M1 and M3 residues impairs GABA signaling via  heteromers. A–C, representative GABA-activated currents, concentration
response curves, and EC50 values for WT and mutant  receptors. ***, p  0.001; n  7–12; one-way ANOVA. D, mean activation, desensitization, and
apparent deactivation waveforms for WT and mutant  receptors in response to 1 mM GABA. Waveforms are normalized to the peak current (n 13–16
traces). E, tilted plan view of the TMD for a pentameric  GABAAR homology model based on the 3 subunit crystal structure (PDB code 4COF) (30). A ring
of M2  helices from each subunit form the ion channel pore. The TMDs for 1 (green), 2 (wheat), and 2 (pink) subunits are shown. Note the interfacial
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impact on 1 receptor activation. The 1W329Amutation largely
removed receptor desensitization and induced faster agonist
deactivation coupled to reduced GABA potency. This con-
trasted with 1W280Q, where GABA potency was increased
along with similar desensitization but slower deactivation rates
compared with WT 1. We created a simple but plausible
receptor kinetic model that incorporated shut states with ago-
nist (A)-unbound (R) and -bound (AR), a further shut statewith
agonist-bound and preactivated (AF), and finally agonist-
bound open (activated) (AO) states with the facility to enter
into desensitized states from the preactivated (AFD) and open
(AOD) states (Model 1).
To account for the altered 1 receptor kinetics, the mutation
W329A virtually eliminated entry into the desensitized
states, AFD and AOD, and the deactivation rate (k-1) was
increased by 10-fold compared with WT 1. For the mutant,
1W280Q, deactivation was decreased by 10-fold to account
for the longer duration “tail” currents. The rate of entry into
the desensitized state, AOD, was also reduced by 30%. Vary-
ing the ion channel gating constants ( and ) and the con-
formational constants (f1, f-1) controlling the preactivated
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Figure 7. Recreating the– subunit interface restores GABA sensitivity to homomers. A, panel of residues in2 at the principal interface () that are
involved in GABA binding in receptors. Corresponding residues at the interface are shown. Note that 50% of these residues were exchanged in the1
homomers as indicated (N, not exchanged; Y, yes, exchanged). B, plan and side views of a GABAAR homologymodel based on the 3 subunit crystal structure
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shows the – interface (green arrows in B) and the four residues (blue) from the 2 subunit that were incorporated into the 1 subunit. D, a similar
view of a subunit interface but now showing the  side (blue arrows in B) and the selected four residues (red) in 1 that were replaced by their 2
counterparts. Residue numbers accord with the mature 1 and 2 subunit proteins. E, GABA-activated currents for 122L heteromers and
1A290W,(,int) homomers expressed in oocytes. GABA concentrations are indicated. F, GABA concentration response profiles normalized to the
maximum response. EC50 values: 122L, 7.1  0.6 
M; 1
A290W,(,int), 18  2 mM. The inset shows the maximum currents activated by saturating
GABA. **, p  0.01; n  5; two-tailed unpaired t test.
Model 1
GABAA receptor trafficking
J. Biol. Chem. (2018) 293(35) 13427–13439 13435
 at U
CL Library Services on O
ctober 1, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
state were unable to simply account for the altered receptor
kinetics.
For the 1 subunit mutations, interestingly, Gln-241 is also a
key binding residue for neurosteroids that potentiate GABAAR
function and can, at higher concentrations, also cause direct
activation (31, 35, 41). Even though spontaneous currents gated
by 1Q241W,L9’S remained unaffected by THDOC in HEK293
cells, in Xenopus oocytes, THDOC directly activated 1A290W
(in M3) but not 1Q241W (in M1). This validates our results
regarding cell surface expression and the role of Gln-241 in the
neurosteroid binding site, which is present in the M3 mutant
homomer but absent from the M1 mutant homomer. These
results also indicate that theGln-241 site is important for direct
activation of GABAARs by THDOC. The critical role of Gln-
241 for neurosteroid binding to GABAARs (35) suggested that
neurosteroids could be important for trafficking by interacting
with this site in the ER and Golgi compartments. Notably, only
1Q241W enabled homomeric receptor expression compared
with other Gln-241 substitutions. The tryptophan substitution
prevents THDOC binding (35), but it also counterintuitively
mimics the effect of THDOC binding by displacing the GABA
concentration–response curve for  GABAARs to the left
(42). Nevertheless, THDOC did not initiate WT 1 subunit
expression at the cell surface. Another interesting observation
is that 1Ala-290 is also a key residue for modulation by volatile
anesthetics. Its mutation prevents potentiation by enflurane
(43). Thus, both 1 trafficking residues (Gln-241 and Ala-290)
are important for positive allosteric modulation of GABAARs.
This “dual role” is interesting because some of the intersubunit
residues that are important for trafficking of heteromers are
also important for ligand binding at GABAARs (44). For these
interfacial residues and for at least the Gln-241 site (an endog-
enous ligand for Ala-290 is so far unknown), there could be an
evolutionary drive to conserve these residues for heteromeric
assembly.
The observation that GABA (at high concentrations) en-
hanced spontaneous currents in oocytes for 1 homomers and,
to a lesser extent, 2L homomers suggests that these subunits
contain a rudimentary GABA-binding site that is presumably
superseded by association of the  and  interfaces, ena-
bling more efficient GABA binding to  heteromers. By
evolving high-affinity GABAARs, rudimentary GABA binding
sites on subunit homomers have presumably been superseded
in heteromeric receptors. By contrast, bicuculline inhibited the
spontaneous current for 1 and 2 homomers. For zolpidem, a
small block of spontaneous currents in 1A290W was observed
only in oocytes. It has been proposed that zolpidem, an 1 sub-
unit-selective benzodiazepine, may bind at the 1–1 subunit
interface in  receptors (34), so it may be capable of modulat-
ing some  homomers.
In conclusion, N-terminal and ICD assembly sequences have
been identified for and  subunits that enable their co-assem-
bly into heteropentameric receptors (10, 11, 20, 24, 45). How-
ever, the newmotifs identified here for of and 2 indicate that
TMDs are equally important and rely just on single-residue
exchanges for cell surface expression.
Experimental procedures
Cell culture and transfections
HEK-293 cells were maintained at 37 °C in 95% air and 5%
CO2 in Dulbecco’s modified Eagle’s medium supplemented
with 10% v/v fetal calf serum, 100 units/ml penicillin-G, 100

g/ml streptomycin, and 2 mM L-glutamine. All medium com-
ponents were obtained from Life Technologies unless other-
wise stated. Cells were plated onto 22-mm glass coverslips
(VWR), coatedwith poly-L-lysine (Sigma), and transfectedwith
cDNAs encoding for GABAAR subunits along with eGFP using
a calcium phosphate method applied 2–3 h after plating (25).
cDNAs and constructs
pEGFP-C1, murineWTmyc-tagged 1, 2, 2L, and human
1 GABAAR cDNAs subcloned into pRK-5 have all been
described previously (1, 2 and were used for the chimeric
1–1 constructs (46) (1–1M1–4, 1–1M1/2, 1–1M3–4,
1–1ICD2-M4, 1BBS–1M4, 1–1M1/M3, 1–1M1, and
1–1M3). A mimotope of 13 amino acids encoding the BBS
was inserted between amino acids 4 and 5 of the mature 1
subunit protein using an inverse PCR adjacent to a myc tag
(Table S1). Gln-241 and Ala-290 of the mature BBS-tagged 1
protein were mutated to single amino acid mutants. Single M1
and M3 residues in 1 were mutated to C233A (1C233A),
M235L (1M235L), C292S (1C292S), and a triple mutant con-
taining S298L, A299S, and L300V (1SAL-LSV). For 1 subunits,
intracellular domain 1 (ICD1, between M1–M2, including
amino acids Asn-247–Glu-249) and intracellular domain 2
(ICD2, between M3–M4, including amino acids Thr-310–
Lys-390) were serially replaced with the GLIC intracellular
loop sequence -SQPARAA- using a similar inverse PCR-
based mutagenesis approach to provide 1-ICD1GLIC and
1-ICD2GLIC. A double ICD1–2GLIC, where both ICDs were
replaced with the GLIC heptapeptide, was created using
1-ICD2GLIC as template and primers for 1-ICD1GLIC. Simi-
lar strategies were employed to replace ICD1 (between Asn-
247–Ser-250) and/or ICD2 with a multiple glycine-serine
(-GGSSGGSS-) flexible linker. The 9’L in the M2 lining of 1
was substituted for a serine (L9’S) using a Kunkel PCR strategy
(47). Four amino acids (S205T, E208S, V211R, and T213S) in
1A290W at the principle () interface were replaced by corre-
sponding residues from the  () interface to recreate the
GABA-binding interface (1A290W,(, int)). Ser-301 in 2LM3
wasmutated to tryptophan (2LS301W), and the 9’ serine in 2L
M2 was substituted for a leucine residue (2LL9’S) using an
inverse PCR approach. Trp-280 in M1 and Trp-329 in M3 of
1 were substituted for glutamine (1W280Q) and alanine
(1W329A), respectively. BBS tags were inserted into the 1-1
chimeras (1BBS-1M1–4, 1BBS-1M1/2, 1BBS-1M3–4, 1BBS-
1ICD2-M4, 1BBS-1M4, 1BBS-1M1/M3, 1BBS-1M1, and
1BBS-1M3) using restriction digestion, with SpeI and PpuMI
ligating the BBS tag containing the 1BBS N terminus fragment
with the respective chimeras.
Whole-cell patch clamp electrophysiology
Whole-cell currents were recorded from transfected HEK293
cells 48 h after transfection by voltage clamp at 30 mV with
GABAA receptor trafficking
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optimized series resistance (Rs 10megaohms) andwhole-cell
membrane capacitance compensation. Borosilicate glass patch
electrodes (resistance of 4–5 megaohms) were filled with an
internal solution containing 120mMCsCl, 1 mMMgCl2, 11 mM
EGTA, 30 mM KOH, 10 mM HEPES, 1 mM CaCl2, and 2 mM
K2ATP (pH 7.2). HEK293 cells were superfused with a saline
solution containing 140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2,
2.52 mM CaCl2, 11 mM glucose, and 5 mM HEPES (pH 7.4).
Membrane currents were filtered at 5 kHz (3 db, 6th pole
Bessel, 36 db per octave).
Picrotoxin inhibition relationships for the spontaneous
membrane currents were generated by measuring the current
(I) at each picrotoxin concentration and normalizing these to
the maximum inhibition achieved by 1 mM picrotoxin (Imax)
before fitting the concentration response relationship with,
I/Imax 1 [(1/1 (IC50/[B])
n)] (Eq. 1)
where B is the concentration of picrotoxin, IC50 is the concen-
tration of picrotoxin causing 50% maximum inhibition of the
spontaneous current, and n is a slope factor.
Concentration response relationships for GABA-activated
membrane currents were generated by measuring the current
(I) at eachGABAconcentration andnormalizing these currents
to the maximal GABA current (Imax). The concentration
response relationship was fitted with the Hill equation,
I/Imax (1/(1 (EC50/[A])
n)) (Eq. 2)
where A is the concentration of GABA, EC50 is the concentra-
tion of GABA causing 50% of the maximal GABA current, and
n is the slope. All concentration response data were curve fitted
in Origin (version 6).
The extent of desensitization was calculated for 1 receptors
at 60 s and for heteromers at 20 s following application of 1
mM (saturating) GABA. The residual current was normalized
to the peak GABA current measured immediately after the
start of GABA application, which was defined as 0% (i.e. no
desensitization).
The deactivation of 1 receptors was calculated by applying 1
mM GABA to activate the receptors and allowing desensiti-
zation to reach steady state at 	60 s, at which point GABA
application was stopped. The deactivating currents (I) were
normalized to the time point at which GABA application was
stopped (Imax), and the curves were fitted to a bi-exponential
function,
I/Imax100 A1(1 e
t/1) A2(1 e
t/2) (Eq. 3)
where t is time, A1 and A2 are areas of the individual exponen-
tial functions, and 1 and 2 are the exponential time constants.
A weighted time constant was reported.
Two-electrode voltage clamp
All procedures on animals were carried out in accordance
with the Animals (Scientific Procedures) Act 1986 and Euro-
pean Union directives on the use of animals for scientific
research. Xenopus laevis oocytes were obtained by removing
ovaries from frogs, followed by incubation for 2–3 h in colla-
genase type I (Worthington) in OR2 solution containing 85mM
NaCl, 5 mM HEPES, and 1 mM MgCl2 (pH 7.6, adjusted with
KOH). Defolliculated oocytes were washed in OR2 and main-
tained at 18 °C inBarth’s solution containing 88mMNaCl, 1mM
KCl, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 2.4
mM NaHCO3, and 10 mM HEPES (pH adjusted to 7.6 with
NaOH). Oocytes were injected with 27.6 nl of GABAAR
homomers at concentrations of 30–60 ng/
l and used for
recordings 2–5 days after injection.
Two-electrode voltage clamp recordings were performed at
room temperature by superfusing oocytes in a recording solu-
tion containing 100 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, and 5mMHEPES (pH adjusted to 7.4 withNaOH) using
an Axoclamp 2B amplifier, a Digidata 1322A interface, and
pClamp 8 (Molecular Devices). Oocytes were voltage-clamped
at60 to110 mV, and currents were digitized at 500 Hz and
filtered at 50 Hz.
Fluorescent-BgTx staining
HEK293 cells were studied 48 h after transfection and
washed with Krebs solution containing 140 mM NaCl, 4.7 mM
KCl, 1.2 mM MgCl2, 2.52 mM CaCl2, 11 mM glucose, and 5 mM
HEPES (pH 7.4) and incubated in 400 nM -BgTx coupled with
Alexa Fluor 555 (-BgTx–AF555; Life Technologies) for 10
min at room temperature, followed by washing and then fixa-
tion in 4% v/v paraformaldehyde (Sigma) for 10 min at room
temperature. The cells were imaged immediately post-fixation
in saline using a Zeiss LSM 510 Meta confocal microscope and
an Achroplan 
40 water differential interference contrast
objective (numerical aperture (NA) 0.8) as described previously
(48). This involved choosing the optimal z-section and acquir-
ing individual images as a mean from 4 scans in 16 bits using a
543-nm helium–neon laser and a 560-nm long-pass filter for
-BgTx–AF555 and a 488 argon laser with a 505- to 530-nm
band pass filter for eGFP. In experiments requiring membrane
permeabilization, cells were labeled with -BgTx–Alexa Fluor
488, followed by fixation with 4% v/v paraformaldehyde for 10
min at room temperature before serial washing (three times) in
PBS (Sigma) and application of 0.1% w/v Triton X-100 (Sigma)
for 10 min at room temperature in 10% v/v fetal calf serum.
Cells were washed to remove the detergent, and 400 nM
-BgTx–AF555 was applied for 30min at room temperature to
label intracellular receptors along with a rabbit primary
antibody against the endoplasmic reticulum marker calnexin
(Abcam, ab22595). Cells were washed and incubated in a goat
anti-rabbit Cy5 antibody (Life Technologies, A10523) before
mounting in ProlongGold (Life Technologies) and used for
imaging.
Immunolabeling of HEK293 cells
48 h after transfection, cells werewashedwithKrebs solution
at 4 °C and incubated in primary antibodies against 2 (Synap-
tic Systems, 224 004) or 1 (Abcam, ab85667) for 30min at 4 °C,
followed by washes, fixation, and incubation in secondary anti-
bodies (goat anti-guinea pig or rabbit Alexa Fluor 555) at room
temperature for 30 min. Cells were washed and imaged imme-
diately after labeling with secondary antibodies.
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Image analysis
Confocal images were analyzed using ImageJ (version 1.410)
as described previously (25). For each cell, the cell surface (CS)
membrane was identified by defining a region of interest (ROI)
in the eGFP channel; thiswas transferred to the-BgTx–AF555
channel (ROICS), and mean membrane fluorescence values
were determined. Mean background (b) fluorescence was
determined from another ROI selected so that it was devoid of
cells (ROIb). This was subtracted from the mean membrane
fluorescence for the cell surface (ROICS), providing amean cor-
rected fluorescence intensity value (ROI  ROICS  ROIb).
These ROI values, for different combinations of receptors,
were graphically plotted using Origin.
Homologymodeling
The primary sequences for murine 1, 2, and 2L subunits
were aligned using ClustalW (49). The mature heteropentam-
eric GABAAR was subsequently modeled based on the crystal
structure template for the GABA 3 subunit homomer (PDB
code 4COF) using Modeler 9 version 7 (50). The models with
the lowest discrete optimized protein energy scores were used,
and optimal side-chain configurations were determined with
SCWRL4 (51). All structural images were visualized and ren-
dered using the PyMOL molecular graphics system (DeLano,
LLC) (40).
Author contributions—T. G. S. and S. H. conceptualization; T. G. S.
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